Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

User Fee Bills: After Mark-ups, How Will House And Senate Reconcile Differences?

Executive Summary

House and Senate committee user fee bill mark-ups approaching, but drafts have differences in drug shortage, supply chain security and other proposed policy changes to reconcile.

Advertisement

Related Content

Conflict of Interest Reform: Greatest Impact May Be Committee Vacancy Rate
Drug Shortages Proposal From Sen. Hatch Offers 7-Year Economic Incentives
Pediatric Reauthorization In Senate Hits Pothole From Cost Offset For Exclusivity
Antibiotic Incentives: FDA’s Woodcock Says LPAD Could Be Better Than Exclusivity, But Questions Remain
Conflict Of Interest Rules Get Clean Sweep In House Draft User Fee Bill
User Fee Package Offers FDA Reforms From A House Wary Of FDA Power
PDUFA Draft Bill Would Broaden FDA’s Mission, Make Guidance Development More Public
Drug Shortages: Can The Blame Game Help Find Solutions?
Drug Shortages: FDA Wants Advanced Warning; Practitioners Want Even More
How "Clean" Will PDFUA V Be? Rep. Pitts Explains His Vacuuming Technique

Topics

Advertisement
UsernamePublicRestriction

Register

PS054382

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel